A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Purpose: Despite the wide adoption of tumor molecular profiling, there is a dearth of evidence linking molecular biomarkers for treatment selection to prediction of treatment outcomes in patients with metastatic pancreatic cancer. We initiated a pilot study to test the feasibility of designing a lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesfaye, Anteneh A., Wang, Hongkun, Hartley, Marion L., He, Aiwu Ruth, Weiner, Louis, Gabelia, Nina, Kapanadze, Lana, Shezad, Muhammad, Brody, Jonathan R., Marshall, John L., Pishvaian, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503449/
https://www.ncbi.nlm.nih.gov/pubmed/31065624
http://dx.doi.org/10.1089/pancan.2019.0003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503449/
https://www.ncbi.nlm.nih.gov/pubmed/31065624
http://dx.doi.org/10.1089/pancan.2019.0003

Ejemplares similares